Transaction · 0001193125-26-410001

Kelly Thomas Patrick

Kelly Thomas Patrick, CFO, reported an open-market or private purchase at Xenon Pharmaceuticals Inc. involving 15000.000000 shares for an estimated $559740.00. Reported holdings after the transaction were 15000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCFO
XENEXenon Pharmaceuticals Inc.
Filing timeOct 01
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNew position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$37.19
Pre-filing
1mo ago +63.3%1w ago -1.7%1d ago +0.2%
Returns since
7d30d90d180d1y

XENE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
XENE since 2026-10-01Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-410001
Common Shares
Transaction date
Sep 30, 2026
Filed Oct 01, 2026, 01:20 PM · 1d delay
Shares
15.0k sh
$37.32 per share
Estimated value
$559k
Computed from shares × price
Holdings after
15.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CFO Buy Cluster Buy Direct Ownership Large Holdings Increase
+54score
Filing-only score

+54

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended

No footnotes recorded.

Original filing · 0001193125-26-410001
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

XENE